Dual Variants of Uncertain Significance in a Case of Hyper-IgM Syndrome: Implications for Diagnosis and Management

Nourhen AGREBI¹Rafah Mackeh¹Mohamed Alsabbagh¹Asha Elmi¹Amnah A Al-Marri¹Satanay Zuhair Hubrack¹Saleema Cherichi Purayil²Afraa Fadul³Amel Hassan^4,5*Bernice Lo^1,6*

• ¹Translational Medicine Department, Research Department, Sidra Medicine, Doha, Qatar
• ²Allergy & Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
• ³Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
• ⁴Department of Allergy and Immunology, Sidra Medicine, Doha, Qatar
• ⁵College of Medicine, Qatar University, Doha, Qatar
• ⁶College of Health & Life Science, Hamad Bin Khalifa University, Doha, Qatar

Background: Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. The overlapping clinical presentations of different gene mutations complicate diagnosis and management.Objective: This study aims to elucidate the clinical implications of concurrent AICDA and IKBKB homozygous variants in a pediatric patient diagnosed with hyper-IgM syndrome. Methods: We present immunological and genetic analysis of a Tunisian patient with two homozygous variants of uncertain significance (VUSs) in the IKBKB and AICDA genes, suspected of causing hyper-IgM and immune deficiency. We conducted functional tests to ascertain the pathogenicity of IKBKB and AICDA mutations and to provide a definitive diagnosis and appropriate management. Results: Genetic analysis identified two homozygous variants: AICDA (p.W80S) and IKBKB (p.R77Q). Immunophenotyping and functional studies found greatly reduced class-switched memory B cells and somatic hypermutations but normal T cell responses and NFkB activation.The simultaneous presence of multiple homozygous VUSs emphasizes a major challenge in the genetic diagnosis of highly consanguinous patients. Functional workup as well as familial segregation studies are needed to clarify variant pathogenicity and provide a definitive diagnosis and tailored treatment strategies for these patients. Our studies suggest that the AICDA p.W80S variant is pathogenic, while the IKBKB p.R77Q variant is likely benign.